Market Hang panelists disagreed on how GLP-1 weight-loss drugs may affect food stocks: one said snack brands already show an impact, while another said Cava and Chipotle could benefit. One panelist said food companies report no effect on results yet.
The panel also discussed corporations dropping insurance coverage for GLP-1s because of costs. A speaker said Bank of America believed the coverage does more good than it costs and was keeping it.
